Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

New Fellow of the Society for Radiological Protection

Awards & Appointments Research

Many congratulations to Dr Mark Hill, who has become a Fellow of the Society for Radiological Protection (FSRP).

Dr Mark Hill was awarded the honour of Fellow of the Society for Radiological Protection (FSRP) in recognition of his significant impact within the field of radiation protection.

Mark has over 30 years of experience in the field of radiation biology and physics. The main focus of his work relates to understanding the mechanisms behind how the spatial and temporal pattern of energy deposition by ionising radiation drives the subsequent biological response and ultimately the associated human health implications.

Alongside his research, Mark has been involved with a number of national and international committees, is Course Director of our MSc in Radiation Biology, lectures on the Annual Radiological Protection Summer School at University of Cambridge, and is a specialist radiobiology examiner on the First FRCR examination board for the Royal College of Radiologists. This year is also due to become a Member of the Committee on Medical Aspects of Radiation in the Environment (COMARE), which provides independent advice to all UK government departments and agencies.

Speaking of the award, Mark said “It is an honour to receive recognition from my peers for all the work I have done over the years”.

Similar stories

Multi-cancer blood test shows real promise in NHS trial

An NHS trial of a new blood test for more than 50 types of cancer correctly revealed two out of every three cancers in more than 5,000 people who had visited their GP with suspected symptoms, in England or Wales. The test also correctly identified the original site of cancer in 85% of those cases.

The Howat Foundation to fund Chair in Clinical Oncology

Oxford Cancer announce the endowment of a Chair in Clinical Oncology, thanks to generous philanthropic support from The Howat Foundation

New Oxford and Nottingham developed tool uses existing health records to predict people’s risk of developing lung cancer within the next 10 years

A team of researchers from the University of Oxford and the University of Nottingham have developed a new tool, called ‘CanPredict’, aimed at identifying the people most at risk of developing lung cancer over the next 10 years, and put them forward for screening tests earlier, saving time, money and, most importantly, lives.

Mark Hill becomes Fellow of the Institute of Physics and Engineering in Medicine

Dr Mark Hill was awarded the honour of Fellow of the Institute of Physics and Engineering in Medicine (FIPEM) after ‘demonstrating scientific and professional attainment of outstanding merit’.

Scientists find genetic ‘marker’ linked to serious side-effects from skin cancer treatment

New research from the Fairfax Group has identified a genetic marker that could be used to predict a patient’s risk of developing serious side-effects when undergoing immunotherapy treatment for metastatic melanoma.

Tiffany Ma wins the inaugural BACR Student Impact Award 2022